Pretherapy Imaging
Pretherapy Imaging is a diagnostic procedure category in nuclear medicine that specifically involves the administration of a radiolabeled ligand prior to therapeutic intervention to visualize, characterize, and quantify target expression in prostate cancer lesions for patient selection and dosimetry planning.
140
Publications
8.1K
Citations
1.1K
Authors
317
Institutions
Publications per year
2017–2026
48
140
Janet S. Rasey, Wui-Jin Koh, Margaret L. Evans et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 563 citations
Medicine, Nuclear Medicine, Oncology +14
John Violet, Price Jackson, Justin Ferdinandus et al. · Journal of Nuclear Medicine · 2018 · 486 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
MRI Surrogates for Molecular Subgroups of Medulloblastoma
Sébastien Perreault, Vijay Ramaswamy, Achal S. Achrol et al. · American Journal of Neuroradiology · 2014 · 322 citations · Full text
1–5 of 140
1.1K
4
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 1.1K
317
University of California, San Francisco
San Francisco, United States
6 h-index
41 publications
2.4K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
5 h-index
46 publications
4.1K citations
University of Washington
Seattle, United States
4 h-index
30 publications
8.3K citations

Johns Hopkins University
Baltimore, United States
4 h-index
16 publications
750 citations

University of Duisburg-Essen
Essen, Germany
4 h-index
16 publications
991 citations
Duke Medical Center
Durham, United States
4 h-index
39 publications
2.2K citations

University of Toronto
Toronto, Canada
4 h-index
12 publications
1.5K citations
University Medical Center Utrecht
Utrecht, The Netherlands
4 h-index
27 publications
1.6K citations
1–8 of 317
14 publications · 1.2K citations
13
h-index
10 publications · 934 citations
10
h-index
CNM · 9 publications · 278 citations
9
h-index
8 publications · 936 citations
8
h-index
6 publications · 246 citations
6
h-index
1–5